Board of Directors

Douglas W. Lehrman

Mr. Lehrman has served as Director since July 2000. Mr. Lehrman is Managing Director at North Castle Partners, LLC in Greenwich, Connecticut. For 17 years prior to founding North Castle with his partners in 1998, Mr. Lehrman was an investment banker specializing in leveraged buyouts.  During that career he was involved with over 50 transactions with a total value of approximately $8 billion. Much of Mr. Lehrman's focus was developing new sources of private capital for growth-oriented companies to achieve their business plans. His focus at North Castle includes Grand Expeditions, its global travel company, a variety of early stage investments including Galileo Laboratories, and Healthnotes, in addition to opportunities in the food, health information and other sectors.

Craig C. Taylor

Mr. Taylor has served as  Director since January 1998. Mr. Taylor is a General Partner of Alloy Ventures, formerly Asset Management, and partner of AMC Partners 89, L.P. Mr. Taylor has been with Asset Management, a venture management group, since 1977. Mr. Taylor is currently a Director of Telor Ophthalmic Pharmaceuticals, Inc., Metra BioSystems, Inc., Lynx Therapeutics, Inc., Pharmacyclics, Inc. and of several private companies. Mr. Taylor holds BS and MS degrees in physics from Brown University and an MBA from Stanford University Graduate School of Business.

Roger Salquist

Mr. Salquist has served as Director since May 1999. Mr. Salquist is a Partner and Managing Director of Bay City Capital ("BCC"), a San Francisco-based merchant bank. BCC is the Advisor and Mr. Salquist is the Chief Investment Officer of the North American Nutrition and Agribusiness Fund, which invests in high-growth-potential companies engaged in technological and business innovation in the nutrition and agribusiness sectors. From 1984 through 1996, Mr. Salquist served as Chairman and Chief Executive Officer of Calgene, Inc. Mr. Salquist currently serves as a Director of Akkadix Corporation, Lifespring, and OmegaTech, Inc. Mr. Salquist is a trustee of the Fidelity Investments Charitable Gift Fund and a member of the Board of Trustees of the University of San Francisco. Mr. Salquist holds a BA and an MBA from Stanford University.

Richard A. Miller, MD

Dr. Miller has served as  Director since January of 1998. Dr. Miller is the President, Chief Executive Officer and a Director of Pharmacyclics, Inc., a public biotechnology company, which he co-founded in April 1991. In 1984, Dr. Miller co-founded IDEC Pharmaceuticals Corporation, a public biotechnology company, where he served as Vice President and a director until February 1992. Dr. Miller also is Clinical Professor of Medicine (Oncology) at Stanford University Medical Center. Dr. Miller received his MD, summa cum laude, from the State University of New York Medical School and is board certified in both Internal Medicine and Medical Oncology.

Terry Gould

Mr. Gould has served as Director since January 1998. Mr. Gould is Executive Director, Direct Investment Team at UBS Brinson. Prior to joining UBS Brinson, Mr. Gould was with Trinity Ventures, Ltd. Earlier in his career, Mr. Gould spent five years as a management consultant, including at the Boston and San Francisco offices of the Boston Consulting Group Inc., an international strategy-consulting firm. Mr. Gould also was a founder of and manager in two successful, entrepreneurial companies, Innovative Leisure and Viasoft. Mr. Gould currently is a Director of Allegis Corporation (formerly Net-It Software) and Network Integrity, Inc. Mr. Gould holds a BA from Dartmouth College and an MBA from the Stanford University Graduate School of Business.

Vicente Anido, PhD

Dr. Anido has served as Director since December 1998. Most recently he served as Chief Executive Officer of CombiChem, Inc. Prior to CombiChem, Inc., Dr. Anido was the President of the Americas Region at Allergan, Inc., where he was responsible for the company's commercial operations in North and South America. Prior to Allergan, Dr. Anido spent approximately 18 years at Marion Laboratories and Marion Merrell Dow. Dr. Anido holds BS and MS degrees in pharmacy and pharmaceutical sciences from West Virginia University and a PhD from the University of Missouri.

Guy Miller, MD, PhD

Dr. Miller, founder and Chief Executive Officer of Galileo Laboratories, serves also as Chairman of the Board of Directors. Before forming Galileo, Dr. Miller was Associate Professor at Johns Hopkins Medical Institutions School of Medicine. After completing a Surgical Internship at the University of Chicago, he completed a residency in Anesthesiology & Critical Care Medicine and a Fellowship in Multidisciplinary Critical Care Medicine at Johns Hopkins. Currently, Dr. Miller is Clinical Instructor, Stanford University School of Medicine. Dr. Miller holds an MD from the Medical College of Pennsylvania and a PhD in Chemistry from the University of Virginia.